| Previous Close | 2.72 |
| Open | 2.72 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 2.65 - 2.73 |
| 52 Week Range | 2.05 - 3.10 |
| Volume | 56,915 |
| Avg. Volume | 52,326 |
| Market Cap | 96.88M |
| Beta | 0.53 |
| PE Ratio (TTM) | -1.42 |
| EPS (TTM) | -1.92 |
| Earnings Date | Dec 4, 2017 - Dec 8, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.33 |
- ACCESSWIRE•5 days ago
Corporate News Blog - Opiant Delivers Update on NARCAN Nasal Spray; Surpasses $25 Million Net Sales in H1 2017
Research Desk Line-up: SeaChange Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 18, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Opiant ...
- GlobeNewswire•11 days ago
SeaChange Strengthens End User Video Experience at IBC2017
ACTON, Mass., Sept. 12, 2017-- Video solutions innovator SeaChange International, Inc. will demonstrate its latest products during IBC2017 highlighting the ability to profitably deliver consumer entertainment ...
- GlobeNewswire•11 days ago
Partner TV OTT Service Launches on SeaChange Adrenalin Platform
ACTON, Mass., Sept. 12, 2017-- SeaChange International, Inc. today announced that Partner Communications, a leading Israeli Telco and Israel’ s second-largest mobile service provider, has launched its ...
